相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target
Aleksandra Babicheva et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Activation of AMPK inhibits Galectin-3-induced pulmonary artery smooth muscle cells proliferation by upregulating hippo signaling effector YAP
Qianqian Zhang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)
Luteolin Ameliorates Experimental Pulmonary Arterial Hypertension via Suppressing Hippo-YAP/PI3K/AKT Signaling Pathway
Wanyun Zuo et al.
FRONTIERS IN PHARMACOLOGY (2021)
Tregs-derived interleukin 35 attenuates endothelial proliferation through STAT1 in pulmonary hypertension
Naifu Wan et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
mTOR Signaling as a Regulator of Hematopoietic Stem Cell Fate
Helia Fernandes et al.
STEM CELL REVIEWS AND REPORTS (2021)
Integrated weighted gene co-expression network analysis uncovers STAT1(signal transducer and activator of transcription 1) and IFI44L (interferon-induced protein 44-like) as key genes in pulmonary arterial hypertension
Han Yang et al.
BIOENGINEERED (2021)
Smooth muscle cell-specific fibronectin-EDA mediates phenotypic switching and neointimal hyperplasia
Manish Jain et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation
Lei Zhang et al.
CELL PROLIFERATION (2020)
Effects of neuromuscular electrical stimulation in patients with pulmonary arterial hypertension: a randomized controlled pilot study
Buse Ozcan Kahraman et al.
JOURNAL OF CARDIOLOGY (2020)
The role of metabolic checkpoint regulators in B cell survival and transformation
Julia Jellusova
IMMUNOLOGICAL REVIEWS (2020)
Wild-type p53-induced phosphatase 1 promotes vascular smooth muscle cell proliferation and neointima hyperplasia after vascular injury via p-adenosine 50′-monophosphate-activatedprotein kinase/mammalian target of rapamycin complex 1 pathway
Xiongshan Sun et al.
JOURNAL OF HYPERTENSION (2019)
Crosstalk between the Akt/mTORC1 and NF-κB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs
Ying Li et al.
ACTA PHARMACOLOGICA SINICA (2019)
RASAL2 Plays Inconsistent Roles in Different Cancers
Bolun Zhou et al.
FRONTIERS IN ONCOLOGY (2019)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer
Yi Pan et al.
MOLECULAR CANCER (2018)
The expression and function of RASAL2 in renal cell carcinoma angiogenesis
Ke Hui et al.
CELL DEATH & DISEASE (2018)
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
Jingyi Liu et al.
NATURE COMMUNICATIONS (2018)
Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
Haiyang Tang et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2018)
SphK1/S1P mediates TGF-beta 1-induced proliferation of pulmonary artery smooth muscle cells and its potential mechanisms
Jian Wang et al.
PULMONARY CIRCULATION (2018)
Upregulation of RASAL2 promotes proliferation and metastasis, and is targeted by miR-203 in hepatocellular carcinoma
Jian-Feng Fang et al.
MOLECULAR MEDICINE REPORTS (2017)
Rasal2 deficiency reduces adipogenesis and occurrence of obesity-related disorders
Xiaoqiang Zhu et al.
MOLECULAR METABOLISM (2017)
Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension
Reza Aghamohammadzadeh et al.
FASEB JOURNAL (2016)
Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis
Annie Christine Lajoie et al.
LANCET RESPIRATORY MEDICINE (2016)
Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension
Haiyang Tang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Adiponectin affects vascular smooth muscle cell proliferation and apoptosis through modulation of the mitofusin-2-mediated Ras-Raf-Erk1/2 signaling pathway
Wenbo Zhang et al.
MOLECULAR MEDICINE REPORTS (2015)
RASAL2 activates RAC1 to promote triple-negative breast cancer progression
Min F Feng et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Where is mTOR and what is it doing there?
Charles Betz et al.
JOURNAL OF CELL BIOLOGY (2013)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
BMPR-II deficiency elicits pro-proliferative and anti-apoptotic responses through the activation of TGF-TAK1-MAPK pathways in PAH
Md Talat Nasim et al.
HUMAN MOLECULAR GENETICS (2012)
A Novel Murine Model of Severe Pulmonary Arterial Hypertension
Loredana Ciuclan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia
Vera P. Krymskaya et al.
FASEB JOURNAL (2011)
Mechanisms of disease: pulmonary arterial hypertension
Ralph T. Schermuly et al.
NATURE REVIEWS CARDIOLOGY (2011)
Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era
Marc Humbert et al.
CIRCULATION (2010)
Interferon-γ induces human vascular smooth muscle cell proliferation and intimal expansion by phosphatidylinositol 3-kinase-dependent mammalian target of rapamycin raptor complex 1 activation
Yinong Wang et al.
CIRCULATION RESEARCH (2007)
分享论文
